CEFAZ
ENGLISH PHARMACEUTICALS INDUSTRIES
Advertisement
Active Ingredients
Indications
Peritonitis, Respiratory tract infections, Meningitis, Septicaemia, Bacteremia, Soft tissue infections, Cystic fibrosis, Skin infections, Ear infection, Joint infections, Biliary infections, Urinary tract infection, Infection in immunocompromised patients, Gastro-intestinal infections, Infected burns, Lung infection, Abdominal infection, Continous ambulatory peritoneal dialysis, Infections associated with haemo and peritoneal dialysis, Bone infection, Throat infections, Nose infection.
Active Ingredients
Indications
Peritonitis, Respiratory tract infections, Meningitis, Septicaemia, Bacteremia, Soft tissue infections, Cystic fibrosis, Skin infections, Ear infection, Joint infections, Biliary infections, Urinary tract infection, Infection in immunocompromised patients, Gastro-intestinal infections, Infected burns, Lung infection, Abdominal infection, Continous ambulatory peritoneal dialysis, Infections associated with haemo and peritoneal dialysis, Bone infection, Throat infections, Nose infection.
Active Ingredients
Indications
Peritonitis, Respiratory tract infections, Meningitis, Septicaemia, Bacteremia, Soft tissue infections, Cystic fibrosis, Skin infections, Ear infection, Joint infections, Biliary infections, Urinary tract infection, Infection in immunocompromised patients, Gastro-intestinal infections, Infected burns, Lung infection, Abdominal infection, Continous ambulatory peritoneal dialysis, Infections associated with haemo and peritoneal dialysis, Bone infection, Throat infections, Nose infection.